Lamotrigine analysis in blood and brain by high-performance liquid chromatography

A reversed-phase high-performance liquid chromatography assay was developed and validated to determine plasma and brain lamotrigine concentrations allowing pharmacokinetic-pharmacodynamic studies of this new antiepileptic drug in patients and laboratory animals. Lamotrigine and its internal standard were extracted, under alkaline conditions, from plasma and brain homogenate, into ethyl acetate; brain proteins were previously precipitated with trichloroacetic acid. The method was linear between 0.1 and 15.0 mg/l for plasma, with a detection limit of 0.008 mg/l, and between 0.1 and 5.0 mg/l for brain homogenate, with a detection limit of 0.023 mg/l. The method proved to be simple, useful and appropriate, not only for clinical and experimental research, but also for routine monitoring of lamotrigine concentrations in patients.http://www.sciencedirect.com/science/article/B6TG9-42T4DX1-G/1/114ff1c7668d24d37232dc1f255aeb1

Parasitémies à Plasmodium falciparum ou P. malariae chez les porteurs du trait drépanocytaire dans différents biotopes du Bénin

La prévalence du paludisme en fonction du phénotype de l'hémoglobine et la fréquence du gène S ont été recherchées dans deux différents biotopes du Bénin. Dans aucun d'eux, la prévalence du paludisme n'est significativement différente entre les porteurs du trait drépanocytaire et les autres. De même, la prévalence du trait drépanocytaire n'est pas modifiée par l'âge. En revanche, en région holoendémique, la densité parasitaire moyenne à #P. falciparum$ est significativement plus faible chez les sujets AS que chez les sujets AA. La présence du trait drépanocytaire ne réduit pas le risque d'infection palustre mais semble diminuer l'importance de la parasitémie. (Résumé d'auteur

Dominant g(9/2)^2 neutron configuration in the 4+1 state of 68Zn based on new g factor measurements

The $g$ factor of the $4_1^+$ state in $^{68}$Zn has been remeasured with improved energy resolution of the detectors used. The value obtained is consistent with the previous result of a negative $g$ factor thus confirming the dominant $0g_{9/2}$ neutron nature of the $4_1^+$ state. In addition, the accuracy of the $g$ factors of the $2_1^+$, $2_2^+$ and $3_1^-$ states has been improved an d their lifetimes were well reproduced. New large-scale shell model calculations based on a $^{56}$Ni core and an $0f_{5/2}1pg_{9/2}$ model space yield a theoretical value, $g(4_1^+) = +0.008$. Although the calculated value is small, it cannot fully explain the experimental value, $g(4_1^+) = -0.37(17)$. The magnitude of the deduced B(E2) of the $4_1^+$ and $2_1^+$ transition is, however, rather well described. These results demonstrate again the importance of $g$ factor measurements for nuclear structure determination s due to their specific sensitivity to detailed proton and neutron components in the nuclear wave functions.Comment: 7 pages, 3 figs, submitted to PL

Topotecan-vincristine-doxorubicin in stage 4 high risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC : a SIOPEN study

Purpose : Metastatic response to induction therapy for high-risk neuroblastoma is a prognostic factor. In the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN) HR-NBL-1 protocol, only patients with metastatic complete response (CR) or partial response (PR) with <= three abnormal skeletal areas on iodine 123-metaiodobenzylguanidine ([I-123] mIBG) scintigraphy and no bone marrow disease proceed to high dose therapy (HDT). In this study, topotecan-vincristine-doxorubicin (TVD) was evaluated in patients failing to achieve these criteria, with the aim of improving the metastatic response rate. Materials and Methods : Patients with metastatic high-risk neuroblastoma who had not achieved the SIOPEN criteria for HDT after induction received two courses of topotecan 1.5 mg/m(2)/day for 5 days, followed by a 48-hour infusion of vincristine, 2 mg/m(2), and doxorubicin, 45 mg/m(2). Results : Sixty-three patients were eligible and evaluable. Following two courses of TVD, four (6.4%) patients had an overall CR, while 28 (44.4%) had a PR with a combined response rate of 50.8% (95% confidence interval [CI], 37.9 to 63.6). Of these, 23 patients achieved a metastatic CR or a PR with <= 3 mIBG skeletal areas and no bone marrow disease (36.5%; 95% CI, 24.7 to 49.6) and were eligible to receive HDT. Toxicity was mostly haematological, affecting 106 of the 126 courses (84.1%; 95% CI, 76.5 to 90.0), and dose reduction was necessary in six patients. Stomatitis was the second most common nonhematological toxicity, occurring in 20 patients (31.7%). Conclusion : TVD was effective in improving the response rate of high-risk neuroblastoma patients after induction with COJEC enabling them to proceed to HDT. However, the long-term benefits of TVD needs to be determined in randomized clinical trials

Shell-Model Effective Operators for Muon Capture in ^{20}Ne

It has been proposed that the discrepancy between the partially-conserved axial-current prediction and the nuclear shell-model calculations of the ratio $C_P/C_A$ in the muon-capture reactions can be solved in the case of ^{28}Si by introducing effective transition operators. Recently there has been experimental interest in measuring the needed angular correlations also in ^{20}Ne. Inspired by this, we have performed a shell-model analysis employing effective transition operators in the shell-model formalism for the transition $^{20}Ne(0^+_{g.s.})+\mu^- \to ^{20}F(1^+; 1.057 MeV) + \nu_\mu$. Comparison of the calculated capture rates with existing data supports the use of effective transition operators. Based on our calculations, as soon as the experimental anisotropy data becomes available, the limits for the ratio $C_P/ C_A$ can be extracted.Comment: 9 pages, 3 figures include

49Cr: Towards full spectroscopy up to 4 MeV

The nucleus 49Cr has been studied analysing gamma-gamma coincidences in the reaction 46Ti(alpha,n)49Cr at the bombarding energy of 12 MeV. The level scheme has been greatly extended at low excitation energy and several new lifetimes have been determined by means of the Doppler Shift Attenuation Method. Shell model calculations in the full pf configuration space reproduce well negative-parity levels. Satisfactory agreement is obtained for positive parity levels by extending the configuration space to include a nucleon-hole either in the 1d3/2 or in the 2s1/2 orbitals. A nearly one-to-one correspondence is found between experimental and theoretical levels up to an excitation energy of 4 MeV. Experimental data and shell model calculations are interpreted in terms of the Nilsson diagram and the particle-rotor model, showing the strongly coupled nature of the bands in this prolate nucleus. Nine values of K(pi) are proposed for the levels observed in this experiment. As a by-result it is shown that the values of the experimental magnetic moments in 1f7/2 nuclei are well reproduced without quenching the nucleon g-factors.Comment: 13 pages, 8 figure

Towards the solution of the CP/CAC_{P}/C_{A} anomaly in shell-model calculations of muon capture

Recently many authors have performed shell-model calculations of nuclear matrix elements determining the rates of the ordinary muon capture in light nuclei. These calculations have employed well-tested effective interactions in large scale shell-model studies. For one of the nuclei of interest, namely $^{28}$Si, there exists recent experimental data which can be used to deduce the value of the ratio $C_{P}/C_{A}$ by using the calculated matrix elements. Surprisingly enough, all the abovementioned shell-model results suggest a very small value ($\simeq 0$) for $C_{P}/C_{A}$, quite far from the PCAC prediction and recent data on muon capture in hydrogen. We show that this rather disturbing anomaly is solved by employing effective transition operators. This finding is also very important in studies of the scalar coupling of the weak charged current of leptons and hadrons.Comment: Revtex, 6 pages, 2 figs include